These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Captopril--an overview. Rosendorff C S Afr Med J; 1982 Oct; 62(17):593-9. PubMed ID: 6214858 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
25. Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure. Duff JM; Moreb JS; Muwalla F Ann Pharmacother; 2012 Jan; 46(1):e1. PubMed ID: 22170976 [TBL] [Abstract][Full Text] [Related]
26. Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature. Chrysant SG; Dunn M; Marples D; DeMasters K Arch Intern Med; 1983 Mar; 143(3):437-41. PubMed ID: 6338847 [TBL] [Abstract][Full Text] [Related]
28. Severe side-effects of captopril in advanced chronic kidney insufficiency. Beroniade V Proc Eur Dial Transplant Assoc; 1983; 20():530-7. PubMed ID: 6228942 [TBL] [Abstract][Full Text] [Related]
29. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension. Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678 [TBL] [Abstract][Full Text] [Related]
30. [Agranulocytosis induced by captopril]. Gómez-Martino Arroyo JR; Jorquera Plaza F; Ordóñez González R; Granda Rodríguez M An Med Interna; 1989 Jul; 6(7):387-8. PubMed ID: 2491496 [No Abstract] [Full Text] [Related]
31. Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants. Gantenbein MH; Bauersfeld U; Baenziger O; Frey B; Neuhaus T; Sennhauser F; Bernet V J Perinat Med; 2008; 36(5):448-52. PubMed ID: 18605972 [TBL] [Abstract][Full Text] [Related]
32. Haematological side effects of clozapine: patient characteristics. Miller PR; Cutten AE N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414 [TBL] [Abstract][Full Text] [Related]
33. Deterioration in renal function in patients with chronic renal failure after treatment with captopril. Boner G; Morduchowicz G; Rotenberg Z; Weinberger I; Shohat J; Rosenfeld JB Isr J Med Sci; 1985 Nov; 21(11):892-4. PubMed ID: 3908397 [TBL] [Abstract][Full Text] [Related]
35. [Reversible renal insufficiency and arterial hypertension after renal transplantation: role of transplant artery stenosis and a captopril-furosemide combination]. Suc JM; Vernier I; Durand D; Giraud P; Segonds-Modesto A; Sarramon JP Nephrologie; 1985; 6(3):155-8. PubMed ID: 3908959 [TBL] [Abstract][Full Text] [Related]
36. Mianserin: a possible cause of neutropenia and agranulocytosis. Adverse Drug Reactions Advisory Committee. Med J Aust; 1980 Dec; 2(12):673-4. PubMed ID: 7219304 [TBL] [Abstract][Full Text] [Related]
37. [Side effects induced by captopril. Comparison of a series of hypertensive patients with renal failure and a series with cardiac failure]. Kayanakis JG; Doat P; Grenet B; Albagnac N; Fauvel JM; Durand D; Suc JM; Bounhoure JP Arch Mal Coeur Vaiss; 1983 Sep; 76(9):1065-71. PubMed ID: 6227300 [TBL] [Abstract][Full Text] [Related]